139 results on '"Verweij Paul E"'
Search Results
2. Potency of Olorofim (F901318) Compared to Contemporary Antifungal Agents against Clinical Aspergillus fumigatus Isolates and Review of Azole Resistance Phenotype and Genotype Epidemiology in China
3. Suboptimal Dosing of Fluconazole in Critically Ill Patients: Time To Rethink Dosing
4. Comparison of MIC Test Strip and Sensititre YeastOne with the CLSI and EUCAST Broth Microdilution Reference Methods for In Vitro Antifungal Susceptibility Testing of Cryptococcus neoformans
5. cyp51A Mutations, Extrolite Profiles, and Antifungal Susceptibility in Clinical and Environmental Isolates of the Aspergillus viridinutans Species Complex
6. In Vitro Activity of Chlorhexidine Compared with Seven Antifungal Agents against 98 Fusarium Isolates Recovered from Fungal Keratitis Patients
7. Elevated MIC Values of Imidazole Drugs against Aspergillus fumigatus Isolates with TR 34 /L98H/S297T/F495I Mutation
8. Potency of Olorofim (F901318) Compared to Contemporary Antifungal Agents against Clinical Aspergillus fumigatusIsolates and Review of Azole Resistance Phenotype and Genotype Epidemiology in China
9. Flucloxacillin Results in Suboptimal Plasma Voriconazole Concentrations
10. Susceptibility Testing of Common and Uncommon Aspergillus Species against Posaconazole and Other Mold-Active Antifungal Azoles Using the Sensititre Method
11. In Vivo Efficacy of Liposomal Amphotericin B against Wild-Type and Azole-Resistant Aspergillus fumigatus Isolates in Two Different Immunosuppression Models of Invasive Aspergillosis
12. Genetic Diversity and In Vitro Antifungal Susceptibility of 200 Clinical and Environmental Aspergillus flavus Isolates
13. In Vitro Antifungal Susceptibility Profiles of 12 Antifungal Drugs against 55 Trichophyton schoenleinii Isolates from Tinea Capitis Favosa Patients in Iran, Turkey, and China
14. Epidemiology and Molecular Characterizations of Azole Resistance in Clinical and Environmental Aspergillus fumigatus Isolates from China
15. Are the TR 46 /Y121F/T289A Mutations in Azole-Resistant Aspergillosis Patient Acquired or Environmental?
16. Quantitative Analysis of Single-Nucleotide Polymorphism for Rapid Detection of TR 34 /L98H- and TR 46 /Y121F/T289A-Positive Aspergillus fumigatus Isolates Obtained from Patients in Iran from 2010 to 2014
17. Altered Micafungin Pharmacokinetics in Intensive Care Unit Patients
18. First Description of Azole-Resistant Aspergillus fumigatus Due to TR 46 /Y121F/T289A Mutation in France
19. Pharmacodynamics of Isavuconazole in an Aspergillus fumigatus Mouse Infection Model
20. The Strength of Synergistic Interaction between Posaconazole and Caspofungin Depends on the Underlying Azole Resistance Mechanism of Aspergillus fumigatus
21. Posaconazole Prophylaxis in Experimental Azole-Resistant Invasive Pulmonary Aspergillosis
22. Intrapulmonary Posaconazole Penetration at the Infection Site in an Immunosuppressed Murine Model of Invasive Pulmonary Aspergillosis Receiving Oral Prophylactic Regimens
23. Amphotericin B- and Voriconazole-Echinocandin Combinations against Aspergillus spp.: Effect of Serum on Inhibitory and Fungicidal Interactions
24. Favorable Outcome of Neonatal Cerebrospinal Fluid Shunt-Associated Candida Meningitis with Caspofungin
25. Pharmacodynamics and Dose-Response Relationships of Liposomal Amphotericin B against Different Azole-Resistant Aspergillus fumigatus Isolates in a Murine Model of Disseminated Aspergillosis
26. Inhibitory and Fungicidal Effects of Antifungal Drugs against Aspergillus Species in the Presence of Serum
27. In Vitro Interaction of Voriconazole and Anidulafungin against Triazole-Resistant Aspergillus fumigatus
28. Pharmacodynamics of Anidulafungin against Clinical Aspergillus fumigatus Isolates in a Nonneutropenic Murine Model of Disseminated Aspergillosis
29. Species-Specific Antifungal Susceptibility Patterns of Scedosporium and Pseudallescheria Species
30. Rapid Induction of Multiple Resistance Mechanisms in Aspergillus fumigatus during Azole Therapy: a Case Study and Review of the Literature
31. Failure of Posaconazole Therapy in a Renal Transplant Patient with Invasive Aspergillosis Due to Aspergillus fumigatus with Attenuated Susceptibility to Posaconazole
32. Impact of cyp51A Mutations on the Pharmacokinetic and Pharmacodynamic Properties of Voriconazole in a Murine Model of Disseminated Aspergillosis
33. Azole Resistance Profile of Amino Acid Changes in Aspergillus fumigatus CYP51A Based on Protein Homology Modeling
34. Efficacy of Posaconazole against Three Clinical Aspergillus fumigatus Isolates with Mutations in the cyp51A Gene
35. International Interlaboratory Proficiency Testing Program for Measurement of Azole Antifungal Plasma Concentrations
36. In Vitro Activities at pH 5.0 and pH 7.0 and In Vivo Efficacy of Flucytosine against Aspergillus fumigatus
37. Potent Synergistic In Vitro Interaction between Nonantimicrobial Membrane-Active Compounds and Itraconazole against Clinical Isolates of Aspergillus fumigatus Resistant to Itraconazole
38. Treatment of Intra-Abdominal Abscesses Caused by Candida albicans with Antifungal Agents and Recombinant MurineGranulocyte Colony-StimulatingFactor
39. Activity of Posaconazole in Treatment of Experimental Disseminated Zygomycosis
40. In Vitro Drug Interaction Modeling of Combinations of Azoles with Terbinafine against ClinicalScedosporium prolificansIsolates
41. In Vitro Synergistic Interaction between Amphotericin B and Pentamidine against Scedosporium prolificans
42. In Vitro Susceptibilities of Zygomycetes to Combinations of Antimicrobial Agents
43. In Vitro Activities of Pentamidine, Pyrimethamine, Trimethoprim, and Sulfonamides against Aspergillus Species
44. Efficacy of Antifungal Therapy in a Nonneutropenic Murine Model of Zygomycosis
45. Method for Measuring Postantifungal Effect in Aspergillus Species
46. Epidemiology and Molecular Characterizations of Azole Resistance in Clinical and Environmental Aspergillus fumigatusIsolates from China
47. In Vitro Interaction of Terbinafine with Itraconazole against Clinical Isolates of Scedosporium prolificans
48. Efficacy of LY303366 against Amphotericin B-Susceptible and -Resistant Aspergillus fumigatus in a Murine Model of Invasive Aspergillosis
49. Quantitative Analysis of Single-Nucleotide Polymorphism for Rapid Detection of TR34/L98H- and TR46/Y121F/T289A-Positive Aspergillus fumigatusIsolates Obtained from Patients in Iran from 2010 to 2014
50. First Description of Azole-Resistant Aspergillus fumigatusDue to TR46/Y121F/T289A Mutation in France
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.